Jazz Pharmaceuticals plc
シンボルマーク: JAZZ
NASDAQ
124.79
USD今日の市場価格
16.5122
PER(株価収益率
0.0368
PEGレシオ
7.78B
MRK キャップ
- 0.00%
DIV利回り
Jazz Pharmaceuticals plc (JAZZ) 財務諸表
貸借対照表
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 5742.22 | 1626.3 | 881.5 | 591.4 | |||||||||||||||||||
balance-sheet.row.short-term-investments | 930 | 420 | 30 | 0 | |||||||||||||||||||
balance-sheet.row.net-receivables | 2567.96 | 705.8 | 651.5 | 563.4 | |||||||||||||||||||
balance-sheet.row.inventory | 2540.86 | 597 | 714.1 | 1072.7 | |||||||||||||||||||
balance-sheet.row.other-current-assets | 754.22 | 334.8 | 267.2 | 252.4 | |||||||||||||||||||
balance-sheet.row.total-current-assets | 12304.18 | 3263.9 | 2606.1 | 2611.3 | |||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 1123.89 | 235 | 301.4 | 343.4 | |||||||||||||||||||
balance-sheet.row.goodwill | 6924.57 | 1753.1 | 1692.7 | 1827.6 | |||||||||||||||||||
balance-sheet.row.intangible-assets | 22305.88 | 5418 | 5794.4 | 7152.3 | |||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 29230.45 | 7171.2 | 7487.1 | 8979.9 | |||||||||||||||||||
balance-sheet.row.long-term-investments | 25.24 | 4.7 | 5.5 | 12 | |||||||||||||||||||
balance-sheet.row.tax-assets | 1771.38 | 477.8 | 376.2 | 311.1 | |||||||||||||||||||
balance-sheet.row.other-non-current-assets | 449.94 | 240.7 | 58.9 | 40.8 | |||||||||||||||||||
balance-sheet.row.total-non-current-assets | 32600.91 | 8129.4 | 8229.1 | 9687.3 | |||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.total-assets | 44905.09 | 11393.4 | 10835.3 | 12298.6 | |||||||||||||||||||
balance-sheet.row.account-payables | 436.48 | 102.8 | 90.8 | 100.3 | |||||||||||||||||||
balance-sheet.row.short-term-debt | 1324.61 | 624.4 | 31 | 31 | |||||||||||||||||||
balance-sheet.row.tax-payables | 231.72 | 35.1 | 7.7 | 9.6 | |||||||||||||||||||
balance-sheet.row.long-term-debt-total | 21794.59 | 5108 | 5765.2 | 6106.1 | |||||||||||||||||||
Deferred Revenue Non Current | 64.26 | 64.3 | 0 | 0.5 | |||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 3531.91 | - | - | - | |||||||||||||||||||
balance-sheet.row.other-current-liab | 3168.01 | 774.5 | 811 | 675.9 | |||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 25853.81 | 6119.7 | 6816.3 | 7524.1 | |||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 297.5 | 64.3 | 71.8 | 87.2 | |||||||||||||||||||
balance-sheet.row.total-liab | 30818 | 7656.4 | 7749.5 | 8333.4 | |||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.common-stock | 0.24 | 0.1 | 0.1 | 0.1 | |||||||||||||||||||
balance-sheet.row.retained-earnings | 3377.81 | 878.7 | 733.6 | 830.2 | |||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -3724.13 | -841.7 | -1125.5 | -400.4 | |||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 14433.16 | 3700 | 3477.6 | 3535.3 | |||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 14087.09 | 3737 | 3085.7 | 3965.2 | |||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 44905.09 | 11393.4 | 10835.3 | 12298.6 | |||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.total-equity | 14087.09 | 3737 | 3085.7 | 3965.2 | |||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 44905.09 | - | - | - | |||||||||||||||||||
Total Investments | 940.2 | 424.7 | 35.5 | 12 | |||||||||||||||||||
balance-sheet.row.total-debt | 23183.46 | 5796.7 | 5796.2 | 6137.1 | |||||||||||||||||||
balance-sheet.row.net-debt | 18191.25 | 4590.3 | 4914.7 | 5545.7 |
キャッシュフロー計算書
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 414.83 | 414.8 | -224.1 | -329.7 | |||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 638.7 | 638.7 | 629.5 | 552.5 | |||||||||||||||||||
cash-flows.row.deferred-income-tax | -260.22 | -260.2 | -292.3 | 69.2 | |||||||||||||||||||
cash-flows.row.stock-based-compensation | 226.84 | 226.8 | 222 | 189 | |||||||||||||||||||
cash-flows.row.change-in-working-capital | -204.44 | -204.4 | 9.9 | -48 | |||||||||||||||||||
cash-flows.row.account-receivables | -51.88 | -51.9 | -90.1 | -92.7 | |||||||||||||||||||
cash-flows.row.inventory | -13.42 | -13.4 | -49.6 | -48.9 | |||||||||||||||||||
cash-flows.row.account-payables | 9.6 | 9.6 | -11.2 | 57 | |||||||||||||||||||
cash-flows.row.other-working-capital | -148.74 | -148.7 | 160.9 | 36.6 | |||||||||||||||||||
cash-flows.row.other-non-cash-items | 276.29 | 276.3 | 926.9 | 345.4 | |||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 1092.01 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -24.96 | -24 | -498.2 | -45.5 | |||||||||||||||||||
cash-flows.row.acquisitions-net | -20 | 0 | 53 | -6234.8 | |||||||||||||||||||
cash-flows.row.purchases-of-investments | -390.1 | -390.1 | -61 | -26.8 | |||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 270 | 270 | 60 | 1095 | |||||||||||||||||||
cash-flows.row.other-investing-activites | 2 | -19 | 0 | 0 | |||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -163.06 | -163.1 | -446.2 | -5212.1 | |||||||||||||||||||
cash-flows.row.debt-repayment | -31 | -31 | -582 | -1320.6 | |||||||||||||||||||
cash-flows.row.common-stock-issued | 46.46 | 46.5 | 98 | 135.3 | |||||||||||||||||||
cash-flows.row.common-stock-repurchased | -313.03 | -269.8 | -0.1 | -35.6 | |||||||||||||||||||
cash-flows.row.dividends-paid | -112.28 | 0 | -98 | -99.7 | |||||||||||||||||||
cash-flows.row.other-financing-activites | 104.59 | -51 | 52.6 | 5291.1 | |||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -305.25 | -305.3 | -529.5 | 3970.5 | |||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 1.14 | 1.1 | -6.2 | -3.2 | |||||||||||||||||||
cash-flows.row.net-change-in-cash | 634.83 | 354.8 | 290 | -466.3 | |||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 4992.22 | 1206.3 | 881.5 | 591.4 | |||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 4357.39 | 851.5 | 591.4 | 1057.8 | |||||||||||||||||||
cash-flows.row.operating-cash-flow | 1092.01 | 1092 | 1272 | 778.5 | |||||||||||||||||||
cash-flows.row.capital-expenditure | -24.96 | -24 | -498.2 | -45.5 | |||||||||||||||||||
cash-flows.row.free-cash-flow | 1067.05 | 1068 | 773.8 | 733 |
損益計算書の行
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 3834.2 | 3834.2 | 3659.4 | 3094.2 | ||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 587.13 | 1043.9 | 540.5 | 440.8 | ||||||||||||||||||||
income-statement-row.row.gross-profit | 3247.07 | 2790.3 | 3118.9 | 2653.5 | ||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||
income-statement-row.row.research-development | 849.66 | - | - | - | ||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.other-expenses | 1286.53 | 1476.9 | 599.2 | 525.8 | ||||||||||||||||||||
income-statement-row.row.operating-expenses | 2587.77 | 2131.1 | 2606.6 | 2483.2 | ||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 3174.9 | 3174.9 | 3147.1 | 2924 | ||||||||||||||||||||
income-statement-row.row.interest-income | 65.2 | 65.1 | 11.5 | 1.8 | ||||||||||||||||||||
income-statement-row.row.interest-expense | 308.77 | 351.1 | 288.2 | 278.8 | ||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -215.41 | -361.4 | -885.1 | -283.1 | ||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 1286.53 | 1476.9 | 599.2 | 525.8 | ||||||||||||||||||||
income-statement-row.row.total-operating-expenses | -215.41 | -361.4 | -885.1 | -283.1 | ||||||||||||||||||||
income-statement-row.row.interest-expense | 308.77 | 351.1 | 288.2 | 278.8 | ||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 632.12 | 638.7 | 599.2 | 525.8 | ||||||||||||||||||||
income-statement-row.row.ebitda-caps | 1290.43 | - | - | - | ||||||||||||||||||||
income-statement-row.row.operating-income | 658.31 | 659.3 | 512.3 | 170.3 | ||||||||||||||||||||
income-statement-row.row.income-before-tax | 297.93 | 297.9 | -372.8 | -112.8 | ||||||||||||||||||||
income-statement-row.row.income-tax-expense | -119.91 | -119.9 | -158.6 | 216.1 | ||||||||||||||||||||
income-statement-row.row.net-income | 414.83 | 414.8 | -214.1 | -329 |
よくある質問
Jazz Pharmaceuticals plcJAZZ 総資産とは何ですか?
Jazz Pharmaceuticals plc (JAZZ) 総資産は 11393359000.000.
企業の年間売上高とは?
年間収益は 1984075000.000である.
企業の利益率は?
利益率は 0.847 である.
企業のフリーキャッシュフローとは?
フリーキャッシュフローは 17.051.
企業の純利益率は?
純利益率は 0.108 である.
企業の総収入は?
総収入は 0.172 である.
Jazz Pharmaceuticals plc (JAZZ) 純利益(純利益)とは何ですか?
純利益(純利益)は 414832000.000.
負債総額は?
負債合計は 5796653000.000 である.
営業費用はいくらですか?
営業費用は 2131063000.000 である.
会社の現金はいくらですか?
企業の現金は 1206310000.000 である.